TriReme Medical Inc. completed its $17 million Series D financing round.
Bio*One Capital PTE LTD led the financing; current investors Three Arch Partners and Adams Street Partners also contributed "strong support," according to Singapore-based Bio*One’s parent company EDB Investments PTE LTD.